Employee Drug Testing:

Agency Costs May Vary From Earlier Estimates

GGD-89-75: Published: May 30, 1989. Publicly Released: Jun 30, 1989.

Additional Materials:


Office of Public Affairs
(202) 512-4800

Pursuant to a congressional request, GAO analyzed the Office of Management and Budget's (OMB) cost estimates for civilian cabinet-level departments' proposed drug testing programs.

GAO found that OMB program guidance: (1) specified a dollar amount for estimating costs of specimen collection, drug testing, personnel, and quality control; (2) based those estimates on the cost information it had available at the time it issued the guidance; (3) allowed agencies to use alternative assumptions to its figures in developing cost estimates; (4) included cost estimates which did not adequately reflect the influence on individual agencies of such factors as employee location and resource availability; and (5) did not recommend specific dollar amounts for employee education or program administration. GAO also found that: (1) most agencies applied the proposed OMB figures in developing program cost estimates; (2) agency size and drug testing program size accounted for differences among agencies' total estimated costs; and (3) agencies' estimated costs for employee education and program administration ranged widely, even after accounting for variations in agency or drug testing program size. GAO believes that: (1) most agency programs are not yet sufficiently developed to determine the overall direction and magnitude of program costs in relation to OMB estimates; and (2) Congress may wish to direct agencies to track and report actual program costs.

Jan 12, 2021

Sep 16, 2020

Feb 25, 2020

Dec 30, 2019

Oct 10, 2019

Oct 2, 2019

Sep 25, 2019

Sep 11, 2019

Aug 15, 2019

Jul 30, 2019

Looking for more? Browse all our products here